Drops Recall: Scope Health Optase Dry Eye
Announced 2026-05-06 · FDA
FDA recall of Optase Dry Eye Intense Drops due to lack of assurance of sterility. The recall covers multiple lots (8T98, 9T31, 9T32, 2V13, 2V14, 2V15, 3V35, 3V36, 3V37, 5V45, 5V46, 9V12, 1X57, 1X70, 1X84) with expiry dates through 2027, distributed nationwide in the United States. Consumers should check their lot numbers and stop using any recalled product.
| Brand | SCOPE HEALTH |
|---|---|
| Product | Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, Manufactured for Scope Health Inc., 79 Madison Ave., 8th Floor, New York, NY 10016, USA, NDC 72972-002-01. |
| Reason | Lack of Assurance of Sterility |
| Severity | moderate |
| Distribution | Nationwide within the United States |
| Agency | FDA |
| Recall / campaign no. | Lot#: 8T98, 9T31, 9T32, Exp. Date: 30/04/26; 2V13, 2V14, 2V15, Exp. Date 30/06/26; 3V35, Exp. Date 31/08/26;3V36, 3V37, Exp. Date 30/09/26; 5V45, 5V46, 9V12, Exp. Date 31/03/27; 1X57, 1X70, 1X84, Exp. Date 31/05/27. |
WHAT YOU SHOULD DO
- Check your bottle's lot number against the recalled lots and stop using any that match.
- Do not use the affected product; dispose of it or return it to the retailer.
- If you have used the product or have symptoms, contact your healthcare provider.
- Visit the FDA recall page or Scope Health customer service for more information.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.